Human Embryonic Stem Cell Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Human Embryonic Stem Cell Market to 2027 - Global Analysis and Forecasts By Product Type (Totipotent Stem Cell, Pluripotent Stem Cell, Unipotent stem Cell); Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing); End User (Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, Others) and Geography

Report Code: TIPRE00005165 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
The human embryonic stem cells are obtained from the undifferentiated inner mass cell of the human embryo and human fetal tissue. The human embryonic stem cell can replicate indefinitely and produce non-regenerative tissue such as myocardial and neural cells. This potential of human embryonic stem cell allows them to provide an unlimited amount of tissue for transplantation therapies to treat a wide range of degenerative diseases. Hence, human embryonic stem cells are used in the treatment of various diseases such as Alzheimer's disease, cancer, blood and genetic disorders related to the immune system and others.

MARKET DYNAMICS
The global human embryonic stem cell market is expected to grow in upcoming years, factors driving the growth of market are rise in incidences of neurological disorders, increase in investment by government and other organization for research activities, awareness among people about stem cell therapeutic potency for disease treatment. On the other hand emerging stem cell banking services is expected to offer lucrative opportunities in growth of human embryonic stem cell market.

MARKET SCOPE
The "Global Human Embryonic Stem Cell Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of human embryonic stem cell market with detailed market segmentation by product type, application, end users and geography. The global human embryonic stem cell market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading human embryonic stem cell market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global human embryonic stem cell market is segmented on the basis of product type, application and end user. Based on product type, the market is segmented as totipotent stem cell, pluripotent stem cell and unipotent stem cell. On the basis of application, the global human embryonic stem cell market is segmented into regenerative medicine, stem cell biology research, tissue engineering and toxicology testing. Based on end users, the market is segmented as therapeutics companies, cell & tissue banks, tools & reagents companies and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global human embryonic stem cell market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The human embryonic stem cell market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting human embryonic stem cell market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human embryonic stem cell market in these regions.
MARKET PLAYERS
The reports cover key developments in the human embryonic stem cell market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from human embryonic stem cell market are anticipated to lucrative growth opportunities in the future with the rising demand for human embryonic stem cell in the global market. Below mentioned is the list of few companies engaged in the human embryonic stem cell market.

The report also includes the profiles of key human embryonic stem cell market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  BD
  •  Takara Bio Inc.
  •  Geron
  •  Thermo Fisher Scientific Inc.
  •  ViaCyte, Inc.
  •  R&D Systems, Inc.
  •  QIAGEN
  •  CellGenix GmbH
  •  Vitrolife
  •  Lonza
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Embryonic Stem Cell Market - By Product Type
1.3.2 Human Embryonic Stem Cell Market - By Application
1.3.3 Human Embryonic Stem Cell Market - By End User
1.3.4 Human Embryonic Stem Cell Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMAN EMBRYONIC STEM CELL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMAN EMBRYONIC STEM CELL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMAN EMBRYONIC STEM CELL MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN EMBRYONIC STEM CELL - GLOBAL MARKET OVERVIEW
6.2. HUMAN EMBRYONIC STEM CELL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMAN EMBRYONIC STEM CELL MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. TOTIPOTENT STEM CELL
7.3.1. Overview
7.3.2. Totipotent Stem Cell Market Forecast and Analysis
7.4. PLURIPOTENT STEM CELL
7.4.1. Overview
7.4.2. Pluripotent Stem Cell Market Forecast and Analysis
7.5. UNIPOTENT STEM CELL
7.5.1. Overview
7.5.2. Unipotent Stem Cell Market Forecast and Analysis
8. HUMAN EMBRYONIC STEM CELL MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. REGENERATIVE MEDICINE
8.3.1. Overview
8.3.2. Regenerative Medicine Market Forecast and Analysis
8.4. STEM CELL BIOLOGY RESEARCH
8.4.1. Overview
8.4.2. Stem Cell Biology Research Market Forecast and Analysis
8.5. TISSUE ENGINEERING
8.5.1. Overview
8.5.2. Tissue Engineering Market Forecast and Analysis
8.6. TOXICOLOGY TESTING
8.6.1. Overview
8.6.2. Toxicology Testing Market Forecast and Analysis
9. HUMAN EMBRYONIC STEM CELL MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. THERAPEUTICS COMPANIES
9.3.1. Overview
9.3.2. Therapeutics Companies Market Forecast and Analysis
9.4. CELL & TISSUE BANKS
9.4.1. Overview
9.4.2. Cell & Tissue Banks Market Forecast and Analysis
9.5. TOOLS & REAGENTS COMPANIES
9.5.1. Overview
9.5.2. Tools & Reagents Companies Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. HUMAN EMBRYONIC STEM CELL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Human Embryonic Stem Cell Market Overview
10.1.2 North America Human Embryonic Stem Cell Market Forecasts and Analysis
10.1.3 North America Human Embryonic Stem Cell Market Forecasts and Analysis - By Product Type
10.1.4 North America Human Embryonic Stem Cell Market Forecasts and Analysis - By Application
10.1.5 North America Human Embryonic Stem Cell Market Forecasts and Analysis - By End User
10.1.6 North America Human Embryonic Stem Cell Market Forecasts and Analysis - By Countries
10.1.6.1 United States Human Embryonic Stem Cell Market
10.1.6.1.1 United States Human Embryonic Stem Cell Market by Product Type
10.1.6.1.2 United States Human Embryonic Stem Cell Market by Application
10.1.6.1.3 United States Human Embryonic Stem Cell Market by End User
10.1.6.2 Canada Human Embryonic Stem Cell Market
10.1.6.2.1 Canada Human Embryonic Stem Cell Market by Product Type
10.1.6.2.2 Canada Human Embryonic Stem Cell Market by Application
10.1.6.2.3 Canada Human Embryonic Stem Cell Market by End User
10.1.6.3 Mexico Human Embryonic Stem Cell Market
10.1.6.3.1 Mexico Human Embryonic Stem Cell Market by Product Type
10.1.6.3.2 Mexico Human Embryonic Stem Cell Market by Application
10.1.6.3.3 Mexico Human Embryonic Stem Cell Market by End User
10.2. EUROPE
10.2.1 Europe Human Embryonic Stem Cell Market Overview
10.2.2 Europe Human Embryonic Stem Cell Market Forecasts and Analysis
10.2.3 Europe Human Embryonic Stem Cell Market Forecasts and Analysis - By Product Type
10.2.4 Europe Human Embryonic Stem Cell Market Forecasts and Analysis - By Application
10.2.5 Europe Human Embryonic Stem Cell Market Forecasts and Analysis - By End User
10.2.6 Europe Human Embryonic Stem Cell Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Human Embryonic Stem Cell Market
10.2.6.1.1 Germany Human Embryonic Stem Cell Market by Product Type
10.2.6.1.2 Germany Human Embryonic Stem Cell Market by Application
10.2.6.1.3 Germany Human Embryonic Stem Cell Market by End User
10.2.6.2 France Human Embryonic Stem Cell Market
10.2.6.2.1 France Human Embryonic Stem Cell Market by Product Type
10.2.6.2.2 France Human Embryonic Stem Cell Market by Application
10.2.6.2.3 France Human Embryonic Stem Cell Market by End User
10.2.6.3 Italy Human Embryonic Stem Cell Market
10.2.6.3.1 Italy Human Embryonic Stem Cell Market by Product Type
10.2.6.3.2 Italy Human Embryonic Stem Cell Market by Application
10.2.6.3.3 Italy Human Embryonic Stem Cell Market by End User
10.2.6.4 Spain Human Embryonic Stem Cell Market
10.2.6.4.1 Spain Human Embryonic Stem Cell Market by Product Type
10.2.6.4.2 Spain Human Embryonic Stem Cell Market by Application
10.2.6.4.3 Spain Human Embryonic Stem Cell Market by End User
10.2.6.5 United Kingdom Human Embryonic Stem Cell Market
10.2.6.5.1 United Kingdom Human Embryonic Stem Cell Market by Product Type
10.2.6.5.2 United Kingdom Human Embryonic Stem Cell Market by Application
10.2.6.5.3 United Kingdom Human Embryonic Stem Cell Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Human Embryonic Stem Cell Market Overview
10.3.2 Asia-Pacific Human Embryonic Stem Cell Market Forecasts and Analysis
10.3.3 Asia-Pacific Human Embryonic Stem Cell Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Human Embryonic Stem Cell Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Human Embryonic Stem Cell Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Human Embryonic Stem Cell Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Human Embryonic Stem Cell Market
10.3.6.1.1 Australia Human Embryonic Stem Cell Market by Product Type
10.3.6.1.2 Australia Human Embryonic Stem Cell Market by Application
10.3.6.1.3 Australia Human Embryonic Stem Cell Market by End User
10.3.6.2 China Human Embryonic Stem Cell Market
10.3.6.2.1 China Human Embryonic Stem Cell Market by Product Type
10.3.6.2.2 China Human Embryonic Stem Cell Market by Application
10.3.6.2.3 China Human Embryonic Stem Cell Market by End User
10.3.6.3 India Human Embryonic Stem Cell Market
10.3.6.3.1 India Human Embryonic Stem Cell Market by Product Type
10.3.6.3.2 India Human Embryonic Stem Cell Market by Application
10.3.6.3.3 India Human Embryonic Stem Cell Market by End User
10.3.6.4 Japan Human Embryonic Stem Cell Market
10.3.6.4.1 Japan Human Embryonic Stem Cell Market by Product Type
10.3.6.4.2 Japan Human Embryonic Stem Cell Market by Application
10.3.6.4.3 Japan Human Embryonic Stem Cell Market by End User
10.3.6.5 South Korea Human Embryonic Stem Cell Market
10.3.6.5.1 South Korea Human Embryonic Stem Cell Market by Product Type
10.3.6.5.2 South Korea Human Embryonic Stem Cell Market by Application
10.3.6.5.3 South Korea Human Embryonic Stem Cell Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Human Embryonic Stem Cell Market Overview
10.4.2 Middle East and Africa Human Embryonic Stem Cell Market Forecasts and Analysis
10.4.3 Middle East and Africa Human Embryonic Stem Cell Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Human Embryonic Stem Cell Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Human Embryonic Stem Cell Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Human Embryonic Stem Cell Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Human Embryonic Stem Cell Market
10.4.6.1.1 South Africa Human Embryonic Stem Cell Market by Product Type
10.4.6.1.2 South Africa Human Embryonic Stem Cell Market by Application
10.4.6.1.3 South Africa Human Embryonic Stem Cell Market by End User
10.4.6.2 Saudi Arabia Human Embryonic Stem Cell Market
10.4.6.2.1 Saudi Arabia Human Embryonic Stem Cell Market by Product Type
10.4.6.2.2 Saudi Arabia Human Embryonic Stem Cell Market by Application
10.4.6.2.3 Saudi Arabia Human Embryonic Stem Cell Market by End User
10.4.6.3 U.A.E Human Embryonic Stem Cell Market
10.4.6.3.1 U.A.E Human Embryonic Stem Cell Market by Product Type
10.4.6.3.2 U.A.E Human Embryonic Stem Cell Market by Application
10.4.6.3.3 U.A.E Human Embryonic Stem Cell Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Human Embryonic Stem Cell Market Overview
10.5.2 South and Central America Human Embryonic Stem Cell Market Forecasts and Analysis
10.5.3 South and Central America Human Embryonic Stem Cell Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Human Embryonic Stem Cell Market Forecasts and Analysis - By Application
10.5.5 South and Central America Human Embryonic Stem Cell Market Forecasts and Analysis - By End User
10.5.6 South and Central America Human Embryonic Stem Cell Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Human Embryonic Stem Cell Market
10.5.6.1.1 Brazil Human Embryonic Stem Cell Market by Product Type
10.5.6.1.2 Brazil Human Embryonic Stem Cell Market by Application
10.5.6.1.3 Brazil Human Embryonic Stem Cell Market by End User
10.5.6.2 Argentina Human Embryonic Stem Cell Market
10.5.6.2.1 Argentina Human Embryonic Stem Cell Market by Product Type
10.5.6.2.2 Argentina Human Embryonic Stem Cell Market by Application
10.5.6.2.3 Argentina Human Embryonic Stem Cell Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HUMAN EMBRYONIC STEM CELL MARKET, KEY COMPANY PROFILES
12.1. BD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TAKARA BIO INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GERON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISHER SCIENTIFIC INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. VIACYTE, INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. R&D SYSTEMS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. QIAGEN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CELLGENIX GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. VITROLIFE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LONZA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. BD
2. Takara Bio Inc.
3. Geron
4. Thermo Fisher Scientific Inc.
5. ViaCyte, Inc.
6. R&D Systems, Inc.
7. QIAGEN
8. CellGenix GmbH
9. Vitrolife
10. Lonza